small molecule

OXACILLIN SODIUM

OXACILLIN SODIUM

Loss of exclusivity—loss of exclusivity
CompanyWOCKHARDT BIO AG

Drug detail

Brand nameOXACILLIN SODIUM
Active ingredientOXACILLIN SODIUM
StrengthEQ 10GM BASE/VIAL
Dosage formINJECTABLE
RouteINJECTION
ModalitySmall molecule
FDA approvalNovember 2017
Marketing statusRX

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.